Mesoblast Ltd (NASDAQ:MESO)

5.77
Delayed Data
As of May 25
 +0.08 / +1.41%
Today’s Change
4.74
Today|||52-Week Range
9.64
-1.20%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close5.69
Today’s open5.70
Day’s range5.67 - 5.78
Volume14,261
Average volume (3 months)51,470
Market cap$518.9M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-1,605.50%
Earnings growth (this year)+53.03%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-95.31%
P/E ratioNM
Price/Sales322.85
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp-0.15-0.92%
RTIXRTI Surgical Inc-0.05-1.09%
SIENSientra Inc-0.01-0.06%
OFIXOrthofix Internation...-0.09-0.16%
Data as of 4:01pm ET, 05/25/2018

Financials

Next reporting dateMay 28, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$1.9M
Annual profit (last year)-$76.8M
Net profit margin-3,951.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts